Search Results - "Furlong, Terry"

Posttransplantation cyclophosphamide for prevention of graft-versus-host disease after HLA-matched mobilized blood cell transplantation by Mielcarek, Marco, Furlong, Terry, O'Donnell, Paul V., Storer, Barry E., McCune, Jeannine S., Storb, Rainer, Carpenter, Paul A., Flowers, Mary E.D., Appelbaum, Frederick R., Martin, Paul J.

“…The cumulative incidence of National Institutes of Health (NIH)-defined chronic graft-versus-host disease (GVHD) requiring systemic treatment is ∼35% at 1 year…”
Get full text

Multi-institutional study of post-transplantation cyclophosphamide as single-agent graft-versus-host disease prophylaxis after allogeneic bone marrow transplantation using myeloablative busulfan and fludarabine conditioning by Kanakry, Christopher G, O'Donnell, Paul V, Furlong, Terry, de Lima, Marcos J, Wei, Wei, Medeot, Marta, Mielcarek, Marco, Champlin, Richard E, Jones, Richard J, Thall, Peter F, Andersson, Borje S, Luznik, Leo

“…The clinical safety and efficacy of intravenous busulfan and fludarabine (IV Bu/Flu) myeloablative conditioning as well as graft-versus-host disease (GVHD)…”
Get full text

Pilot study of lithium to restore intestinal barrier function in severe graft-versus-host disease by Steinbach, Gideon, Hockenbery, David M, Huls, Gerwin, Furlong, Terry, Myerson, David, Loeb, Keith R, Fann, Jesse R, Castilla-Llorente, Christina, McDonald, George B, Martin, Paul J

“…Severe intestinal graft-vs-host disease (GVHD) after allogeneic hematopoietic cell transplantation (HCT) causes mucosal ulceration and induces innate and…”
Get full text

Post-Transplantation Cyclophosphamide for Prevention of Graft-Versus-Host Disease after HLA-Matched Related and Unrelated Donor Peripheral Blood Stem Cell Transplantation by Mielcarek, Marco, MD, Furlong, Terry, RN, O'Donnell, Paul V., MD, PhD, Storer, Barry E., PhD, McCune, Jeannine S., PharmD, Storb, Rainer F., MD, Carpenter, Paul A., MD, Flowers, Mary E.D., MD, Appelbaum, Frederick R., MD, Martin, Paul J., MD

Get full text

Evaluation of Oral Beclomethasone Dipropionate for Prevention of Acute Graft-versus-Host Disease by Martin, Paul J, Furlong, Terry, Rowley, Scott D, Pergam, Steven A, Lloid, Michele, Schubert, Mark M, Horgan, Kevin J, Storer, Barry E

“…Results from two randomized trials have shown that oral beclomethasone dipropionate (BDP) is effective for treatment of acute gastrointestinal…”
Get full text

Low immunosuppressive burden after HLA-matched related or unrelated BMT using posttransplantation cyclophosphamide by Kanakry, Christopher G., Bolaños-Meade, Javier, Kasamon, Yvette L., Zahurak, Marianna, Durakovic, Nadira, Furlong, Terry, Mielcarek, Marco, Medeot, Marta, Gojo, Ivana, Smith, B.Douglas, Kanakry, Jennifer A., Borrello, Ivan M., Brodsky, Robert A., Gladstone, Douglas E., Huff, Carol Ann, Matsui, William H., Swinnen, Lode J., Cooke, Kenneth R., Ambinder, Richard F., Fuchs, Ephraim J., de Lima, Marcos J., Andersson, Borje S., Varadhan, Ravi, O'Donnell, Paul V., Jones, Richard J., Luznik, Leo

“…The intensive and prolonged immunosuppressive therapy required to prevent or treat graft-versus-host disease (GVHD) after allogeneic blood or marrow…”
Get full text

The Use of Post-Transplantation Cyclophosphamide after Myeloablative, HLA-Matched Allogeneic Bone Marrow Transplantation Minimizes the Need for Additional Immunosuppression by Kanakry, Christopher G., MD, Bolaños-Meade, Javier, MD, Kasamon, Yvette L., MD, Zahurak, Marianna, MS, Durakovic, Nadira, MD, Furlong, Terry, RN, Medeot, Marta, MD, Mielcarek, Marco, MD, Borrello, Ivan M., MD, Brodsky, Robert A., MD, Gladstone, Douglas E., MD, Huff, Carol Ann, MD, Matsui, William H., MD, Swinnen, Lode J., MD, Ambinder, Richard F., MD, PhD, Fuchs, Ephraim J., MD, MBA, de Lima, Marcos, MD, Andersson, Borje S., MD, PhD, Varadhan, Ravi, PhD, O'Donnell, Paul V., MD, PhD, Jones, Richard J., MD, Luznik, Leo, MD

Get full text

Impact of Donor Statin Treatment on Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation by Rashid, Nahid, Gooley, Ted, Furlong, Terry, Lee, Stephanie J., Martin, Paul J., Storb, Rainer, Mielcarek, Marco

“…•Short-term donor statin treatment was ineffective in preventing severe acute graft-versus-host disease (GVHD).•Longer-term statin use in donors was…”
Get full text

Initial therapy of acute graft-versus-host disease with low-dose prednisone does not compromise patient outcomes by Mielcarek, Marco, Storer, Barry E., Boeckh, Michael, Carpenter, Paul A., McDonald, George B., Deeg, H. Joachim, Nash, Richard A., Flowers, Mary E.D., Doney, Kristine, Lee, Stephanie, Marr, Kieren A., Furlong, Terry, Storb, Rainer, Appelbaum, Frederick R., Martin, Paul J.

“…We hypothesized that initial treatment of acute graft-versus-host disease (GVHD) with low-dose glucocorticoids (prednisone-equivalent dose of 1 mg/kg per day)…”
Get full text

Alpha 1 Anti-Trypsin (AAT) Offers Potent Therapy for Steroid Resistant Gut Gvhd: Interim Results of a Phase I/II Clinical Study by Marcondes, A. Mario Q., Sorror, Mohamed L., Karoopongse, Ekapun, Furlong, Terry, Lesnikova, Marina, Janciauskiene, Sabina, Dinarello, Charles A., Deeg, H. Joachim

“…Background: Graft-versus-host disease (GVHD) is a major complication of allogeneic hematopoietic cell transplantation (HCT). Severe acute GVHD of the…”
Get full text

Multi-institutional study of allogeneic bone marrow transplantation using myeloablative busulfan (Bu)/fludarabine (Flu) conditioning and short-course, single-agent graft-versus-host disease (GVHD) prophylaxis with high-dose, post-transplantation cyclophosphamide (PTCy) by Kanakry, Christopher George, O'Donnell, Paul V., De Lima, Marcos J.G., Wei, Wei, Furlong, Terry, Medeot, Marta, Jones, Richard J., Thall, Peter F., Andersson, Borje, Luznik, Leo

“…Abstract only 7006 Background: The clinical efficacy of 1) myeloablative BuFlu and 2) PTCy as GVHD prophylaxis have been independently shown in multiple…”
Get full text

Post-Transplantation Cyclophosphamide Following Busulfan and Fludarabine Myeloablative Conditioning Prevents Severe Acute and Chronic Graft-Versus-Host Disease and Minimizes Duration Of Immunosuppression: Results Of a Multi-Institutional Trial In Patients With High-Risk Hematologic Malignancies by Kanakry, Christopher G., O'Donnell, Paul, Furlong, Terry, de Lima, Marcos J, Wei, Wei, Medeot, Marta, Mielcarek, Marco, Champlin, Richard E, Jones, Richard J., Thall, Peter F., Andersson, Borje S., Luznik, Leo

“…Allogeneic blood or marrow transplantation (alloBMT) involves a multi-faceted platform with each component having significant implications for the overall…”
Get full text

Psoralen and ultraviolet A irradiation (PUVA) as therapy for steroid-resistant cutaneous acute graft-versus-host disease by Furlong, Terry, Leisenring, Wendy, Storb, Rainer, Anasetti, Claudio, Appelbaum, Frederick R, Carpenter, Paul A, Deeg, H.Joachim, Doney, Kristine, Kiem, Hans-Peter, Nash, Richard A, Sanders, Jean E, Witherspoon, Robert, Thompson, Dianne, Martin, Paul J

“…Psoralen plus ultraviolet A irradiation (PUVA) has immunomodulatory effects and is used to treat a variety of immune-mediated dermatologic diseases. We…”
Get full text

A pilot pharmacologic biomarker study of busulfan and fludarabine in hematopoietic cell transplant recipients by McCune, Jeannine S., Woodahl, Erica L., Furlong, Terry, Storer, Barry, Wang, Joanne, Heimfeld, Shelly, Deeg, H. Joachim, O’Donnell, Paul V.

“…Purpose Sixteen patients diagnosed with various hematologic malignancies participated in a phase II study evaluating the addition of rabbit antithymocyte…”
Get full text

Sirolimus (rapamycin) for the treatment of steroid-refractory acute graft-versus-host disease by BENITO, Ana I, FURLONG, Terry, WITHERSPOON, Robert, DEEG, H. Joachim, MARTIN, Paul J, ANASETTI, Claudio, APPELBAUM, Frederick R, DONEY, Kris, NASH, Richard A, PAPAYANNOPOULOU, Thalia, STORB, Rainer, SULLIVAN, Keith M

“…In a pilot trial we evaluated the toxicity and efficacy of sirolimus (rapamycin) as second-line therapy for the treatment of acute graft-versus-host disease…”
Get full text

Therapy with mycophenolate mofetil for refractory acute and chronic graft-versus-host disease by Furlong, Terry, Martin, Paul, Flowers, Mary E.D., Carnevale-Schianca, Fabrizio, Yatscoff, Randy, Chauncey, Thomas, Appelbaum, Frederick R., Deeg, H. Joachim, Doney, Kris, Witherspoon, Robert, Storer, Barry, Sullivan, Keith M., Storb, Rainer, Nash, Richard A.

“…We evaluated the pharmacokinetics and efficacy of oral mycophenolate mofetil (MMF) for treatment of refractory graft-versus-host disease (GVHD). In a…”
Get full text

FK506 in Combination With Methotrexate for the Prevention of Graft-Versus-Host Disease After Marrow Transplantation From Matched Unrelated Donors by Nash, Richard A., Pineiro, Luis A., Storb, Rainer, Deeg, H.Joachim, Fitzsimmons, William E., Furlong, Terry, Hansen, John A., Gooley, Ted, Maher, Rochelle M., Martin, Paul, McSweeney, Peter A., Sullivan, Keith M., Anasetti, Claudio, Fay, Joseph W.

“…The safety and potential efficacy of FK506 in combination with a short course of methotrexate (MTX) for the prevention of acute graft-versus-host disease…”
Get full text

Tacrolimus (FK506) Alone or in Combination With Methotrexate or Methylprednisolone for the Prevention of Acute Graft-Versus-Host Disease After Marrow Transplantation From HLA-Matched Siblings: A Single-Center Study by Nash, Richard A., Etzioni, Ruth, Storb, Rainer, Furlong, Terry, Gooley, Ted, Anasetti, Claudio, Appelbaum, Frederick R., Doney, Kristine, Martin, Paul, Slattery, John, Sullivan, Keith, Jagt, Richard van der, Witherspoon, Robert, Jusko, William J., Zager, Richard A., Deeg, H.Joachim

“…The pharmacokinetics, safety, and efficacy in marrow transplantation of FK506-based immunosuppression for graft-ver-sus-host disease (GVHD) prophylaxis was…”
Get full text

A Retrospective Comparison of Tacrolimus versus Cyclosporine with Methotrexate for Immunosuppression after Allogeneic Hematopoietic Cell Transplantation with Mobilized Blood Cells by Inamoto, Yoshihiro, Flowers, Mary E.D, Appelbaum, Frederick R, Carpenter, Paul A, Deeg, H. Joachim, Furlong, Terry, Kiem, Hans-Peter, Mielcarek, Marco, Nash, Richard A, Storb, Rainer F, Witherspoon, Robert P, Storer, Barry E, Martin, Paul J

“…This retrospective study was performed to compare results with tacrolimus versus cyclosporine in combination with methotrexate for immunosuppression after…”
Get full text

A Phase I/II Study of Mycophenolate Mofetil in Combination with Cyclosporine for Prophylaxis of Acute Graft-versus-Host Disease after Myeloablative Conditioning and Allogeneic Hematopoietic Cell Transplantation by Nash, Richard A., Johnston, Laura, Parker, Pablo, McCune, Jeannine S., Storer, Barry, Slattery, John T., Furlong, Terry, Anasetti, Claudio, Appelbaum, Frederick R., Lloid, Michele E., Deeg, H. Joachim, Kiem, Hans-Peter, Martin, Paul J., Schubert, Mark M., Witherspoon, Robert P., Forman, Stephen J., Blume, Karl G., Storb, Rainer

“…In a phase I/II study, the combination of cyclosporine (CSP) and mycophenolate mofetil (MMF) was investigated as graft-versus-host disease (GVHD) prophylaxis…”
Get full text